Mechanistically, we found that CDCA5 promoted the binding of E2F transcription factor 1 (E2F1) to FOXM1 promoter, and Wnt/β-catenin signaling was required for CDCA5 induced development of breast cancer. This evidence concerns the gene CDCA5 and breast cancer.